N-(Ethylamino) Fluvoxamine

• CAT Number: R012360
• CAS Number: 1217262-11-7
• Molecular Formula: C17H26F3N3O2
• Molecular Weight: 361.409
• Purity: ≥95%
• Synonyms: N-[2-[[[(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethyl]etane-1,2-diamine; EP Impurity F; 5-Methoxy-1-[4-(trifluoromethyl)phenyl]- 1-pentanone O-[2-[(2-Aminoethyl)amino]ethyl]oxime; ?
• Storage: -20°C
• IUPAC Name: N/'-[2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethyl]ethane-1,2-diamine
• InChI: InChI=1S/C17H26F3N3O2/c1-24-12-3-2-4-16(23-25-13-11-22-10-9-21)14-5-7-15(8-6-14)17(18,19)20/h5-8,22H,2-4,9-13,21H2,1H3/b23-16+
• InChIKey: YBAOCNUGFGRFPC-XQNSMLJCSA-N
• SMILES: COCCCCC(=NOCCNCCN)C1=CC=C(C=C1)C(F)(F)F

N-(Ethylamino) Fluvoxamine is a derivative of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine, used in pharmaceutical research. It is important for studying the pharmacokinetics, pharmacodynamics, and metabolic pathways of fluvoxamine and its analogs. This compound aids in understanding the drug’s mechanism of action and optimizing its therapeutic efficacy for treating psychiatric disorders. Researchers rely on N-(Ethylamino) Fluvoxamine for precise and reliable results in advanced drug development and mental health research, contributing significantly to innovations in psychiatric treatments.